Related Experiment Videos
[Acrodermatitis enteropathica in childhood (author's transl)]
Klinische Padiatrie
|November 1, 1977
Summary
A five-month-old infant with acrodermatitis enteropathica (AE) highlights the disease's causes and progression. Zinc substitution is presented as a superior alternative to oxychinolin therapy due to fewer side effects.
Area of Science:
- Pediatric Dermatology
- Nutritional Science
- Gastroenterology
Context:
- A five-month-old infant presented with symptoms indicative of acrodermatitis enteropathica (AE).
- The case report details the etiological factors and pathogenesis of AE.
- The clinical course of the disease in this infant is thoroughly documented.
Purpose:
- To describe the etiology, pathogenesis, and clinical presentation of acrodermatitis enteropathica in an infant.
- To evaluate the side effects associated with oxychinolin therapy for AE.
- To demonstrate the advantages and benefits of zinc supplementation as a treatment for AE.
Summary:
- The study details a case of acrodermatitis enteropathica (AE) in a five-month-old infant, outlining its causes and disease progression.
- Oxychinolin therapy was administered, but its associated side effects were noted.
- Substitution with zinc proved to be a more beneficial and safer therapeutic approach, highlighting zinc's crucial role in AE management.
Impact:
- This case underscores the importance of early diagnosis and appropriate management of acrodermatitis enteropathica.
- It provides evidence for the efficacy and safety of zinc supplementation in treating AE, potentially improving patient outcomes.
- The findings contribute to understanding the therapeutic landscape for inborn errors of zinc metabolism.